Cargando…

Titrating Optimal Dose of Osmotic-Controlled Release Oral Delivery (OROS)-Methylphenidate and Its Efficacy and Safety in Korean Children with ADHD: A Multisite Open Labeled Study

OBJECTIVE: This study was aimed to determine effectiveness and tolerability of Osmotic-controlled Release Oral delivery (OROS) methylphenidate (MPH) and its optimal dose administered openly over a period of up to 12 weeks in drug naïve Korean children with ADHD. METHODS: Subjects (n=143), ages 6 to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Dong-Ho, Choi, Soul, Joung, Yoo Sook, Ha, Eun Hye, Kim, Boong-Nyun, Shin, Yee-Jin, Shin, Dongwon, Yoo, Hee Jeong, Cheon, Keun-Ah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neuropsychiatric Association 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440475/ https://www.ncbi.nlm.nih.gov/pubmed/22993525 http://dx.doi.org/10.4306/pi.2012.9.3.257

Ejemplares similares

Variability of Response Time as a Predictor of Methylphenidate Treatment Response in Korean Children with Attention Deficit Hyperactivity Disorder
por: Lee, Seung-Hye, et al.
Publicado: (2009)

Switching from Methylphenidate-Immediate Release (MPH-IR) to Methylphenidate-OROS (OROS-MPH): A Multi-center, Open-label Study in Korea
por: Kim, Bung-Nyun, et al.
Publicado: (2011)

Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate
por: Ginsberg, Ylva, et al.
Publicado: (2012)

Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder
por: Kim, Boong-Nyun, et al.
Publicado: (2010)

Prediction of sleep side effects following methylphenidate treatment in ADHD youth
por: Yoo, Jae Hyun, et al.
Publicado: (2019)

The Impact of Depressive Symptoms in Adults with ADHD Symptoms on Family Function and ADHD Symptoms of Their Children
por: Hong, Soon-Beom, et al.
Publicado: (2014)

ADHD, Methylphenidate, and Childhood Epilepsy
por: Sharma, Rahul, et al.
Publicado: (2016)

Dose titration of osmotic release oral system methylphenidate in children and adolescents with attention-deficit hyperactivity disorder: a retrospective cohort study
por: Xu, Youran, et al.
Publicado: (2023)

Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder
por: Park, Subin, et al.
Publicado: (2012)

The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
por: Bieś, Rafał, et al.
Publicado: (2023)

The WHO Adult ADHD Self-Report Scale: Reliability and Validity of the Korean Version
por: Kim, Ji-Hae, et al.
Publicado: (2013)

Effect of Methylphenidate on Sleep Parameters in Children with ADHD
por: Lee, Sang Heon, et al.
Publicado: (2012)

Postural Instability in Children with ADHD Is Improved by Methylphenidate
por: Bucci, Maria P., et al.
Publicado: (2016)

The Effect of Methylphenidate on Neurological Soft Signs in ADHD
por: Hrtanek, Igor, et al.
Publicado: (2015)

The effect of methylphenidate-OROS(®) on the narrative ability of children with attention-deficit hyperactivity disorder
por: Rausch, Tessa L., et al.
Publicado: (2017)

Association Between 5-HTTLPR Polymorphism and Tics after Treatment with Methylphenidate in Korean Children with Attention-Deficit/Hyperactivity Disorder
por: Park, Seo Yeon, et al.
Publicado: (2015)

Social adjustment and family function after drug switch from IR-methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder
por: Chou, Wen-Jiun, et al.
Publicado: (2018)

Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate
por: Engert, Veronika, et al.
Publicado: (2008)

Randomised controlled trial of the short-term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention-deficit/hyperactivity disorder (CIAO-II)
por: Asherson, Philip, et al.
Publicado: (2019)

Association Between Tic Aggravation and Methylphenidate in Youth With Attention-Deficit/Hyperactivity Disorder
por: Cha, Jung Yoon, et al.
Publicado: (2021)

Incidence of Neutropenia with Valproate, Antipsychotics, and ADHD Medication Combination Treatment in Children and Adolescents
por: Oh, Yunhye, et al.
Publicado: (2020)

PM342. Treatment effect of Methylphenidate on Functional Brain Network in children with ADHD: findings from multivariate pattern analysis
por: Yoo, Jae Hyun, et al.
Publicado: (2016)

The influence of methylphenidate on the power spectrum of ADHD children – an MEG study
por: Wienbruch, Christian, et al.
Publicado: (2005)

Methylphenidate significantly improves declarative memory functioning of adults with ADHD
por: Verster, Joris C., et al.
Publicado: (2010)

Comorbidities in ADHD children treated with methylphenidate: a database study
por: Kraut, Angela A, et al.
Publicado: (2013)

Predicting Methylphenidate Response in ADHD Using Machine Learning Approaches
por: Kim, Jae-Won, et al.
Publicado: (2015)

Reduced pain perception in children and adolescents with ADHD is normalized by methylphenidate
por: Wolff, Nicole, et al.
Publicado: (2016)

Skin picking disorder comorbid with ADHD successfully treated with methylphenidate
por: Bernardes, Camila, et al.
Publicado: (2018)

Moderators and Other Predictors of Methylphenidate Response in Children and Adolescents with ADHD
por: D’Aiello, Barbara, et al.
Publicado: (2022)

Alpha/beta-gamma decoupling in methylphenidate medicated ADHD patients
por: Zammit, Nowell, et al.
Publicado: (2023)

Methylphenidate treatment of adult ADHD patients improves the degree of ADHD severity under routine conditions
por: Retz, Wolfgang, et al.
Publicado: (2020)

Methylphenidate Use for Emotional Dysregulation in Children and Adolescents with ADHD and ADHD and ASD: A Naturalistic Study
por: Ventura, Patrizia, et al.
Publicado: (2022)

Methylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage
por: Chermá, Maria D., et al.
Publicado: (2016)

Bioequivalence of Sandoz methylphenidate osmotic-controlled release tablet with Concerta® (Janssen-Cilag)
por: Schapperer, Elisabeth, et al.
Publicado: (2015)

Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
por: Buitelaar, Jan K, et al.
Publicado: (2009)

Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD
por: Buitelaar, Jan K., et al.
Publicado: (2012)

The Effects of Methylphenidate on Goal-directed Behavior in a Rat Model of ADHD
por: Natsheh, Joman Y., et al.
Publicado: (2015)

Methylphenidate-Induced Psychotic Symptoms in 65-Year-Old Female with ADHD
por: Ghadrdan, Elliyeh, et al.
Publicado: (2018)

Potential Negative Effects of Dextromethorphan as an Add-On Therapy to Methylphenidate in Children With ADHD
por: Chuang, Wei-Chen, et al.
Publicado: (2019)

Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients
por: Solleveld, Michelle M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b7k071b65ihci9ugfoms3rfbfp